Ysios Capital portfolio

Ysios Capital (Venture capital) is known to hold 46 companies, 13 of them startups. 9 of them are hiring now, with 2,563 open roles. Its companies closed 4 venture rounds in 12 months, raising $447.7M. Most of them work in Prescription Drugs, Biologics & Biosimilars, Cardiovascular Devices.

Source: Alion Venture capital Oct 18, 2026
Investments
46
13 of them startups
Hiring now
9
2,563 open roles
Rounds in 12 months
4
$447.7M raised
Exits
11

Companies Ysios Capital has invested in

Xeltis Cardiovascular Devices · Netherlands Venture round $22.1M · 2 mo ago 5 roles portfolio pageSep 25
Ona Therapeutics Series B $86.6M · 4 mo ago portfolio pageSep 25
PLEASE READ THIS AG Denmark Venture round $285M · 11 mo ago portfolio pageSep 25
SpliceBio Series B $135M · 16 mo ago portfolio pageSep 25
ReproNovo Fertility & IVF Series A $65M · 16 mo ago portfolio pageSep 25
Neurona Therapeutics Cell & Gene Therapy · United States Venture round $101.7M · 18 mo ago portfolio pageSep 25
Engrail Therapeutics Prescription Drugs Series B $157M · 2 yr ago portfolio pageSep 25
CorWave Cardiovascular Devices · France Series C $65.9M · 3 yr ago 3 roles portfolio pageSep 25
VarmX Series B $32.4M · 3 yr ago portfolio pageSep 25
Minoryx Prescription Drugs Venture round $55.1M · 4 yr ago portfolio pageSep 25
Anaconda Biomed Venture round $2.6M · 5 yr ago portfolio pageSep 25
synendos Switzerland Series A $22.4M · 5 yr ago portfolio pageSep 25
Barostim Cardiovascular Devices · United States Venture round $50M · 6 yr ago 6 roles portfolio pageSep 25
Amgen Biologics & Biosimilars · United States 1273 roles portfolio pageSep 25
Takeda Pharmaceutical Prescription Drugs · Japan 987 roles portfolio pageSep 25
Qiagen Diagnostic Tests & IVD · Netherlands 105 roles portfolio pageSep 25
Lundbeck Neurology & CNS Therapeutics · Denmark 33 roles portfolio pageSep 25
Mineralys Therapeutics Prescription Drugs · United States 23 roles portfolio pageSep 25
Aura Biosciences Drug Discovery · United States 2 roles portfolio pageSep 25
Abbott Cardiovascular Devices portfolio pageSep 25
Adcendo Biologics & Biosimilars portfolio pageSep 25
AM Pharma Business Development portfolio pageSep 25
EIF Supply Chain portfolio pageSep 25
Fusion Pharma Nuclear Energy · Canada portfolio pageSep 25
Inbiomotion Precision Medicine portfolio pageSep 25
KALA Bio Biologics & Biosimilars portfolio pageSep 25
Tagworkspharma Oncology Therapeutics portfolio pageSep 25
Unpri United Kingdom portfolio pageSep 25
Valuat AI Agents · Spain portfolio pageSep 25
Vivet Therapeutics Network Security · France portfolio pageSep 25

Open roles at Ysios Capital portfolio companies

Digital Enablement Lead, GLECTakeda Pharmaceutical · this month Associate IS Analyst – Veeva Vault QualityAmgen · this month Principal Scientist, Synthetic Molecules Characterization & Attribute Sciences, Analytical DevelopmentTakeda Pharmaceutical · this month National Oncology Sales Training Manager - United States FieldAmgen · this month Sr. Manager Global Cost AccountingAmgen · this month Front Line Manufacturing Manager (Bulk Drug Substance - Upstream) - Night ShiftAmgen · this month National Account Manager- Employer EngagementAmgen · this month Senior Manager Portfolio Marketing - UPLIZNAAmgen · this month Associate Director: Clinical Supply Chain- Logistics and Vendor ManagementAmgen · this month Finance Business Partner LeadTakeda Pharmaceutical · this month Talent Intelligence PartnerTakeda Pharmaceutical · this month US Region Real Estate & Facilities Co-opTakeda Pharmaceutical · this month Facilities Asset Management & Process Improvement Co-opTakeda Pharmaceutical · this month Co Op Program: Global Procurement - Strategic ProjectsTakeda Pharmaceutical · this month People Experience Partner, Employee Relations AmericasTakeda Pharmaceutical · this month People Experience Partner, Employee Relations EuropeTakeda Pharmaceutical · this month People Solutions Advisor - Cluster Lead (Mexico)Takeda Pharmaceutical · this month Global Process Manager – Intake to ContractTakeda Pharmaceutical · this month People Solutions Advisor Team LeadTakeda Pharmaceutical · this month People Experience Partner, Employee Relations APAC & MEATakeda Pharmaceutical · this month
2,563 open roles at 9 of its companies

Focus

Markets
Prescription Drugs13%
Biologics & Biosimilars9%
Cardiovascular Devices9%
Medical AI7%
Neurology & CNS Therapeutics7%
Cardiometabolic Therapeutics4%
Precision Medicine4%
Rare Disease Therapeutics4%
Where its companies are
United States11%
France4%
Denmark4%
Netherlands4%
Spain2%
Canada2%
Switzerland2%
Japan2%
Stage of its companies
Venture, series not stated46%
Series B31%
Series A15%
Series C and later8%

Questions about Ysios Capital

How many companies has Ysios Capital invested in?

Ysios Capital is known to hold 46 companies: 13 startups, and 11 exits so far, read from its own portfolio page and the funding rounds that name it.

Is Ysios Capital investing now?

Ysios Capital has no round in the press in 12 months and no new company on its portfolio page in 90 days.

What does Ysios Capital invest in?

The markets of the companies Ysios Capital holds: Prescription Drugs (13%), Biologics & Biosimilars (9%), Cardiovascular Devices (9%), Medical AI (7%), Neurology & CNS Therapeutics (7%).

Which Ysios Capital portfolio companies are hiring?

9 companies Ysios Capital holds are hiring now, with 2,563 open roles listed on this page.

Who does Ysios Capital invest alongside?

The investors that hold the most companies together with Ysios Capital: Kurma Partners, Asabys Partners, Novartis Venture Fund, RA Capital Management, OrbiMed.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 3

Ysios Capital portfolio: 46 known companies. Alion, Oct 18, 2026. https://alion.io/company/ysios-capital/portfolio

Licence: CC BY-SA 4.0JSON